Company Data
NGM Biopharmaceuticals Inc.
Ticker
NGM
Current Price
$1.54
Market Cap
$128.5M
Price Target
Refer to Report
Volume
21.0K
52wk Range
$0.6002 - $2.515
Overview
NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases. The company’s products include NGM282 (aldafermin), NGM313 (MK-3655), NGM120, NGM120, NGM621, and NGM395, all these are focused on NASH, diabetes, oncology, AMD and metabolic disease.